Aptar and Lupin to launch connected smart device for respiratory disease

ADHERO, India’s first connected device for metered-dose inhalers

409

Aptar Pharma, a global leader in drug delivery systems, services, and active packaging solutions, has recenty announced that it has partnered with Lupin to launch India’s first connected device for metered-dose inhalers (MDI) called ADHERO. This unique add-on smart device is designed to help patients with chronic respiratory diseases track their MDI usage and facilitate improved adherence to their prescribed therapy.

Inhalers are the preferred treatment option for managing the rising incidence of chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) in India. However, it is estimated that nearly 45% of patients do not adhere to their therapy, including the filling and refilling of prescriptions or maintaining the prescribed medication schedule. This inconsistent adherence adversely impacts clinical outcomes and the patient’s quality-of-life. This new device, ADHERO, is designed to improve patient adherence to therapy.

ADHERO is a Bluetooth-enabled, reusable smart device that attaches to the top of an MDI. With built-in sensors, the device tracks the patient’s daily medication usage and consumption patterns. Patients can access this information by connecting their ADHERO device to the ‘MyAdhero’ app on their smartphones. The app is also equipped to send reminders, offer contextual health alerts based on factors like the Air Quality Index at the patient’s current location, and enable visual analytics. Patients can also grant their physician access to their information and medical tracking data through the dashboard portal as well as the app. Aptar Pharma collaborated with Navia Life Care to develop the digital ecosystem for the MyAdhero App, which includes the Patient App, Care Provider App, and the Doctor Portal.

Speaking about the launch, Rajeev Sibal, president – Formulations, Lupin India said, “Lupin lays great emphasis on three aspects of respiratory medicine, namely disease awareness, diagnosis, and adherence. The launch of ADHERO will be a great help to patients using metered dose inhalers to buy inhalers online matched better to them as well as for doctors to track adherence and compliance to therapy, thereby improving clinical outcomes and the quality-of-life of patients.”

Kanwal Tikoo, president, Aptar Pharma’s India & Southeast Asia division, commented, “We are pleased to have partnered with Lupin on their ADHERO connected device program in India. With the steady rise in cases of asthma and COPD, this is an important step towards helping to improve adherence and health outcomes.”

Sai Shankar, vice president – Global Digital Healthcare Systems, Aptar Pharma, added, “Aptar Pharma has been building a portfolio of connected devices within the digital medicines ecosystem. We are focused on integrating services across device development and manufacturing, the digital platform experience, and implementation with the healthcare stakeholders. We are excited about the first launch of a connected inhaler program for respiratory diseases in India with Lupin.”

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here